Julien Mancini Selected Research

VV-hemorphin-7

2/2013

Serum hemorphin-7 levels are decreased in obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julien Mancini Research Topics

Disease

15	Neoplasms (Cancer) 01/2021 - 11/2008
11	Acute Coronary Syndrome 01/2021 - 12/2009
6	Hemorrhage 11/2021 - 08/2010
6	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2012
4	Obesity 09/2021 - 02/2013
4	Hypertension (High Blood Pressure) 01/2019 - 02/2013
3	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2014
3	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 03/2014
3	Type 2 Diabetes Mellitus (MODY) 09/2021 - 04/2012
3	Endocarditis 12/2020 - 11/2008
3	Thrombosis (Thrombus) 12/2019 - 07/2011
2	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 09/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2021 - 07/2011
2	Dyslipidemias (Dyslipidemia) 09/2021 - 03/2017
2	Insulin Resistance 09/2021 - 02/2013
2	Cystic Fibrosis (Mucoviscidosis) 05/2021 - 01/2013
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 10/2020
2	Myocardial Infarction 01/2021 - 07/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 04/2015
2	Pain (Aches) 07/2018 - 05/2018
2	Pneumothorax 11/2017 - 09/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017 - 07/2015
2	Heart Failure 03/2017 - 02/2017
2	Subcutaneous Emphysema 09/2014 - 01/2013
2	Wounds and Injuries (Trauma) 05/2014 - 03/2013
2	Glioma (Gliomas) 05/2012 - 05/2012
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2012 - 01/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012 - 06/2011
1	COVID-19 05/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021
1	Adenomyosis 03/2021
1	Leiomyoma (Uterine Fibroids) 03/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Stroke (Strokes) 01/2021
1	Overweight 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Fatigue 01/2020
1	Tonsillar Neoplasms 01/2020
1	Ischemia 12/2019
1	Aortic Aneurysm (Aneurysm, Aortic) 09/2019
1	Sinusitis 01/2019
1	Endometrial Stromal Sarcoma 01/2019
1	Nasal Obstruction 01/2019
1	Rhinitis 01/2019

Drug/Important Bio-Agent (IBA)

7	TicagrelorIBA 01/2021 - 03/2014
7	Clopidogrel (Plavix)FDA Link 12/2019 - 12/2009
3	Triglycerides (Triacylglycerol)IBA 09/2021 - 04/2012
3	Lipoproteins (Lipoprotein)IBA 09/2021 - 04/2012
3	Insulin (Novolin)FDA Link 09/2021 - 04/2012
3	AntibodiesIBA 01/2021 - 03/2012
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 07/2011
3	Prasugrel Hydrochloride FDA Link 10/2018 - 07/2011
3	Biological ProductsIBA 08/2014 - 11/2010
2	Pharmaceutical PreparationsIBA 05/2022 - 05/2018
2	Apolipoprotein C-IIIIBA 09/2021 - 03/2017
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020 - 08/2017
2	erucylphosphocholineIBA 01/2019 - 01/2015
2	Opioid Analgesics (Opioids)IBA 12/2018 - 07/2018
2	Bevacizumab (Avastin)FDA Link 04/2015 - 05/2012
2	Adenosine (Adenocard)FDA LinkGeneric 06/2014 - 03/2014
2	Biomarkers (Surrogate Marker)IBA 10/2013 - 07/2010
2	Peptides (Polypeptides)IBA 02/2013 - 11/2009
2	Inosine Triphosphate (ITP)IBA 02/2012 - 01/2012
2	belimumabIBA 01/2012 - 06/2011
1	CreatinineIBA 11/2021
1	Growth Hormone (Somatotropin)IBA 09/2021
1	ivacaftorIBA 05/2021
1	lumacaftorIBA 05/2021
1	ulipristal acetate FDA Link 03/2021
1	pembrolizumabIBA 01/2021
1	NivolumabIBA 01/2021
1	thienopyridineIBA 01/2021
1	beta-Aminoethyl Isothiourea (AET)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Proton Pump InhibitorsIBA 01/2021
1	vasodilator-stimulated phosphoproteinIBA 12/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 09/2019
1	10-N-nonylacridinium orange (NAO)IBA 01/2019
1	Gemcitabine FDA Link 01/2019

Therapy/Procedure

22	Therapeutics 01/2022 - 11/2008
7	Percutaneous Coronary Intervention 01/2021 - 08/2010
5	Drug Therapy (Chemotherapy) 01/2020 - 09/2012
3	Aftercare (After-Treatment) 05/2022 - 01/2021
3	Stents 12/2019 - 07/2011
3	Pancreaticoduodenectomy 10/2017 - 07/2015
2	Palliative Care (Palliative Therapy) 08/2020 - 01/2019
2	Length of Stay 11/2017 - 09/2011
2	Resuscitation 03/2013 - 01/2013
1	Cardiopulmonary Resuscitation (CPR) 01/2021
1	Chemoradiotherapy 10/2020
1	Tonsillectomy 01/2020
1	General Anesthesia 01/2020
1	Endovascular Aneurysm Repair 09/2019
1	Ostomy 01/2019
1	Hysterectomy 01/2019
1	Drug-Eluting Stents 01/2019